Patient Scenario 2: 1L Management of ES-SCLC Positive for Synaptophysin With a Ki-67 Score of 90%
Expert oncologists present the case of a 45-year-old woman with synaptophysin-positive, extensive-stage small-cell lung cancer with a Ki-67 score of 90%, who is treated with carboplatin, etoposide, and atezolizumab in the first-line setting, and provide their initial impressions.
Evolving Treatment Strategies Small Cell Lung Cancer Synaptophysin With Ex Sclc Extensive Stage Small Cell Lung Cancer Asco 2023
Source: onclive.com